• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

Hash Rate Collapse

Bitcoin Letter

It’s no secret that the price of Bitcoin is directly correlated to a growing hash rate.

These are truly one of the essential indicators of the underlying health of Bitcoin.  

As buy and sell volume increases in the network, mining introduces more liquidity by delivering fresh coins, and the activity increases when more people buy and sell bitcoin.

This unwritten contract keeps supply and demand in check as the steady flow of newly minted coins lurches ever closer to the final tally of 21 million Bitcoin.

However, I never said there wouldn’t be bumps on the road on the way there.

It’s no coincidence that the price of bitcoin has been slowed down because of the exorbitant energy prices around the world.

Higher energy costs are having a ripple effect where crypto mining companies are adversely affecting by a slowing hash rate.

A developing and healthy mining infrastructure is critical to a higher bitcoin price and what I am seeing are short-term bottlenecks that can only be resolved with easing conditions.

What is hash rate?

Hash rate is the measure of computational power used to verify transactions and add blocks in a Proof-of-work (PoW) blockchain. Bitcoin, among others, utilizes mining to mint new coins and verify transactions.

Hash rate can represent the number of individuals or entities in the world participating in the process of mining. Therefore, the more people mining bitcoin, the higher is the hash rate.

Why is hash rate important in mining?

The mining process, which involves miners solving complex computational puzzles to add blocks to the blockchain, leads to a more secure network.

In addition, miners have an incentive to mine for higher prices.

This system of reward ensures that there will always be new coins added to the economy of bitcoin while keeping the integrity of the blockchain network.

Mining is a business and miners can’t successfully mine if expenses are high combined with a low bitcoin price.

Once a miner produces a coin, it’s common to sell that coin back into the marketplace to recoup the costs of running a mining operation.

Higher rewards lead to a virtuous loop of higher prices and higher revenue while the opposite results in a vicious feedback loop that turns into a downward spiral.

The hash rate has decreased by around 5% in the last few months.

The hash rate recovered well from last summer when China banned Bitcoin and miners fled abroad to restart operations.

These are the growing pains in order to stabilize a new asset class.

The infrastructure of a new asset class doesn’t get built in one day and hopefully, the hash rate can shrug off the latest pullback.

Yet we face an upcoming summer with spiking electricity prices across the world as one of the world's largest exporters of fossil fuels, Russia, is enthralled in a military conflict and global energy supply chains are being severed by sanctions.

Unfortunately, Kazakhstan, the 2nd largest Bitcoin mining country, is facing some more short-term squeezes as Kazakh authorities said they seized almost $200 million of equipment from crypto mining operations as they crack down on illicit mines.

Legally operating miners in Kazakhstan had their power cut off at the end of January, as the government grappled with energy shortages.

The withdrawal of capacity from Kazakhstan is currently limiting bitcoin's hash rate growth.

This might feel highly esoteric because these events happen thousands of miles away.

But it matters because Bitcoin is still vulnerable to supply shocks just like the global supply chains are.

Deteriorating hash rates could signal to traders to delay Bitcoin purchases and as Bitcoin is also fighting with other assets for fiat currency, the incremental trader could be inclined to pay for groceries, gas, and housing before they dip back into the crypto market.

If the hash rate starts to tick upwards as we head into the summer, this could be the genesis of a Bitcoin rally.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-19 13:02:092022-04-19 17:54:15Hash Rate Collapse
Mad Hedge Fund Trader

Quote of the Day - April 19, 2022

Bitcoin Letter

“I would trade all of my technology for an afternoon with Socrates.” – Said Co-Founder of Apple Steve Jobs

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/04/steve-jobs.png 428 336 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-19 13:00:082022-04-19 17:50:11Quote of the Day - April 19, 2022
Mad Hedge Fund Trader

April 19, 2022

Diary, Newsletter, Summary

Global Market Comments
April 19, 2022
Fiat Lux

Featured Trade:

(WHERE THE ECONOMIST “BIG MAC” INDEX FINDS CURRENCY VALUE TODAY),
(UUP), (FXE), (FXY), (CYB)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-19 09:04:132022-04-19 13:03:34April 19, 2022
Mad Hedge Fund Trader

April 18, 2022

Tech Letter

Mad Hedge Technology Letter
April 18, 2022
Fiat Lux

Featured Trade:

(OMINOUS SIGN FOR TECH EARNINGS)
(NFLX)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-18 17:04:032022-04-18 17:58:51April 18, 2022
Mad Hedge Fund Trader

Ominous Sign for Tech Earnings

Tech Letter

A market nostrum I religiously follow of not catching a falling knife could not resonate more with the current situation at streaming giant Netflix (NFLX).

The stock has imploded from $690 to $330 in less than 6 months.

November 2021 represented the high-water mark for many tech growth stocks and NFLX has been dragged into this mess as institutions and hedge funds rush to de-lever their tech portfolio as the panic of higher rates sets into the trading environment.

Does this mark the end to the NFLX model that was the darling of this bull market for so long?

Investors must grapple with this salient question.

NFLX must tap into the bond market to secure funding in order to supply us with high-quality content, so this question is really the crux of the issue.

We are certainly reaching an inflection point where many questions are still in need of answers.

As we approach NFLX’s earnings report tomorrow, the bar has been set extremely low for NFLX.

The backdrop is poor with weekly earnings adjusted for inflation decelerating at the fastest since the housing crisis of 2008.

There’s not a lot to look forward to in the tech world as higher expenses are destroying demand, delaying capital investments, and wage increases are depressing the bottom line at a time when supply chain bottlenecks are going from bad to awful.

NFLX is a product that isn’t essential to daily life like energy or food and non-essential services are the services that are getting cut in 2022.

NFLX also has a Russia problem as the company suspended operations in Russia on March 6 with no end in sight to when or if they might return.

Russia had 1 million NFLX subscribers which only represents a drop in the bucket of the 221 million total NFLX subscribers.

Therefore, I must say that the hit to the bottom line will be miniscule if anything.

However, this proves the point of NFLXs arduous slog through iterating in the emerging world. It’s not as easy when you enter a territory with different rules, currency, culture, and rule of law.

For instance, NFLX isn’t even allowed in China and India has fierce competition from local streaming bulwarks.

If they want to return to Russia, NFLX must first answer to breaking Russian law when they refused to abide by a new law that would require the streamer to include 20 "free-to-air" Russian State TV channels.

NFLX remains heavily focused on the emerging world as it looks to aggressively expand its footprint overseas. Four Russian originals were in the midst of production prior to the suspension. The projects have since been put on ice indefinitely.

Sadly, the saturation of NFLX’s cash cow in America and other rich Western democracies has reared its ugly head.

A multipronged revenue slowdown could spiral out of control.

The low-hanging fruit has been plucked and NFLX is still a model that relies on explosive growth to net the incremental subscriber.

It’s not working anymore and there is no plan B which could result in underperformance of the content quality.  

Most of the bullishness in the stock’s price action coalesces around higher than expected subscription adds and without that, there is a dark future waiting for NFLX.

In addition to subscriber growth, analysts predict that management will have to answer other key questions, with a particular focus on business operations and profitability, the company's password sharing crackdown, gaming strategy, M&A, and more.

In the near term, NFLX’s guide is more important than ever.

In the heat of deglobalization, a leveraged globalized strategy triggers cognitive dissonance. A strategic reset is needed.

I can envision NFLX winning in some countries and losing in others, but to copy and paste that strategy to every emerging country, which usually has a weak rule of law, sounds like a recipe for continuous weak guidance in the new normal we are in.

Even more worrisome, as high inflation bites more at home, Americans might start to cut back on their NFLX and substitute it with free ads on YouTube and that’s the tail risk that’s not baked into the price of the stock yet.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-18 17:02:112022-04-18 17:59:24Ominous Sign for Tech Earnings
Mad Hedge Fund Trader

Quote of the Day - April 18, 2022

Tech Letter

“Don't be afraid to change the model.” – Said Co-Founder and Co-CEO of Netflix Reed Hastings

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/04/reed-hastings.png 484 298 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-18 17:00:552022-04-18 17:58:18Quote of the Day - April 18, 2022
Mad Hedge Fund Trader

April 18, 2022

Diary, Newsletter, Summary

Global Market Comments
April 18, 2022
Fiat Lux

Featured Trade:

(MARKET OUTLOOK FOR THE WEEK AHEAD, or GET READY TO SELL IN MAY)
($INDU), (SPY), (TLT), (WFC), (JPM), (TSLA), (TWTR)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-18 09:04:522022-04-18 16:02:55April 18, 2022
Mad Hedge Fund Trader

The Market Outlook for the Week Ahead, or Get Ready to Sell in May

Diary, Newsletter

So when you are supposed to “Sell in May and go away”, what are you supposed to be doing on April 18?

Not much.

War, inflation, disease, runaway energy prices, and soaring interest rates are usually not a good backdrop for trading stocks. When the wind is blowing against me with gale-force winds instead of behind me, I tend to quit. I only like playing games that are rigged in my favor, or in yours.

Retreating to fight another day sounds like a good strategy to me because it’s much easier to dig out of a small hole than a large one. And it’s impossible to recover if you lost all your money chasing marginal low-quality trades. That 100-day cruise around the world that Cunard is offering right now looks pretty good. If the central bank says it is set on slowing the economy, believe it. The free Fed put is a distant memory.

But whatever Armageddon we are facing out there, it will be a modest one. We now have an unemployment rate of 3.6%, but there are still 11 million open jobs. That means there are more jobs in the US right now than workers, a first in history.

There are in fact several big positives the markets are ignoring right now because it is fashionable to do so. You know these supply chain problems? They’re slowly going away. You see this in falling freight rates for US truckers.

The Cass Freight Index measure of domestic shipping demand edged up a bare 0.6% in March from the month before, an unseasonable slowing of growth at the end of the quarter. From where I sit, the number of Chinese container ships at anchor in San Francisco Bay is on a definite decline.

Going into real recessions, consumers usually baton down the hatches, don their hard hats, and reign in spending. And while they tell pollsters they are worried about the economy, they act like they believe in the opposite, spending with reckless abandon. Wells Fargo (WFC) has seen spending on credit cards soaring by 33% in Q1, while it has jumped by an impressive 29% at JP Morgan (JPM).

There is also a great positive out there which is being completely ignored by the market. The pandemic is gone. Daily cases have dropped from one million to only 20,000 in two months, a record drop in the history of epidemiology. Masks are now only required at mass events like rock concerts and the San Francisco Ballet.

So I will endeavor to entertain you with my stories long enough to keep you from getting bored until trading stocks becomes the slam dunk no-brainer affair it once was. That would be in anything from 2-5 months.

Elon Musk makes $53 billion takeover bid for Twitter in a move that gobsmacked Wall Street. He made the offer in a 281-character tweet to the board of directors. His goal will be to end all censorship, which means bringing back the crazies and the violent. If they don’t accept his premium offer, then he will sell the 9.9% of shares that he already owns and the board will get sued to death by shareholders.

Inflation jumps to 8.5% YOY, a 40-year high, with half of the increase coming from gasoline prices. Stocks and bonds were up on a “buy the rumor, sell the news” move. Unless oil prices completely collapse, next month will be worse.

Producer Price Index rockets by 11.2%, an 11-year high. This is on the heels of yesterday’s red hot Core Inflation report. It makes a half-point rate hike on April 29 a sure thing.

Retail Sales jumped 0.5% in March, and up 6.9% YOY, while import prices hit an 11-year high.

Bonds hit new three-year lows, with yields soaring to 2.81% overnight. The market is transitioning from a Fed that is raising rates from a quarter point at each meeting to a half point. We may be reaching the end of this leg down, off $9.00 in weeks. Only sell the big rallies. (TLT) LEAPS holders are sitting pretty.

Mortgage Refis down 67% YOY, thanks to a 30-year fixed rate mortgage that has topped 5.0%. It looks like the loan sharks won’t be grabbing as much in fees. This market won’t recover for several years. If you didn’t refi last year at century low rates, you’re screwed.

NVIDIA downgraded from outperform to neutral and the price target was chopped from $360 to $225 by Baird & Co. It’s a bold move as (NVDA) has long been a Mad Hedge favorite and 70-bagger over the last five years. Baird cites cancellations driven by a combination of excess GPUs, or graphics processing unit in Western Europe and Asia, as well as a slowdown in consumer demand, especially in China. Slowing consumer demand for GPUs was evident in the continuing reduction in graphics card pricing. I believe any slowdowns are temporary and you should keep buying (NVDA) on dips.

Used Car Sales take a hit, as affordability becomes a major issue. Carmax just reported a 6.5% plunge in Q4. I can sell my Tesla Model X for more than I paid three years ago because it takes a year to get a new one.

Weekly Jobless Claims hit 185,000, up 18,000 from the previous week. The stock market may be worried about a coming recession but the jobs market sure isn’t.

Morgan Stanley blows away earnings. Equity trading came in a hot $3.2 billion and bond trading $2.9 billion. The shares popped 7% on the news. Buy (MS) on dips.

Mercedes breaks 600 miles range on a single charge with its EQXX prototype, driving from Stuttgart to the French Riviera. But the cost per watt is still double Tesla’s. Mercedes plans to go all-electric by the end of the decade.

My Ten-Year View

When we come out the other side of pandemic, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. With interest rates still historically cheap, oil peaking out soon, and technology hyper accelerating, there will be no reason not to. The Dow Average will rise by 800% to 240,000 or more in the coming decade. The America coming out the other side of the pandemic will be far more efficient and profitable than the old. Dow 240,000 here we come!

My March month-to-date performance retreated to a modest 0.38%. My 2022 year-to-date performance ended at a chest-beating 27.23%. The Dow Average is down -5.1% so far in 2022. It is the greatest outperformance on an index since Mad Hedge Fund Trader started 14 years ago. My trailing one-year return maintains a sky-high 68.55%.

On the next capitulation selloff day, which might come with the April Q1 earnings reports, I’ll be adding long positions in technology, banks, and biotech. I am currently in a rare 100% cash position awaiting the next ideal entry point.

That brings my 13-year total return to 539.79%, some 2.10 times the S&P 500 (SPX) over the same period. My average annualized return has ratcheted up to 44.36%, easily the highest in the industry.

We need to keep an eye on the number of US Coronavirus cases at 80.6 million, up only 300,000 in a week and deaths topping 988,000 and have only increased by 3,000 in the past week. You can find the data here. Growth of the pandemic has virtually stopped, with new cases down 98% in two months.

On Monday, April 18 at 7:00 AM EST, the NAHB Housing Market Index is out. Bank of America (BAC) reports.

On Tuesday, April 19 at 8:30 AM, Housing Starts for March are published. Netflix (NFLX) reports.

On Wednesday, April 20 at 8:30 AM, the Existing Home Sales for March are printed. Tesla (TSLA) reports.

On Thursday, April 22 at 7:30 AM, the Weekly Jobless Claims are printed. Union Pacific (UNP) reports.

On Friday, April 23 at 8:30 AM, the S&P Global Composite Flash PMI is disclosed. American Express (AXP) reports. At 2:00 PM, the Baker Hughes Oil Rig Count are out.

As for me, the call from Washington DC was unmistakable, and I knew what was coming next. “How would you like to serve your country?” I’ve heard it all before.

I answered, “Of course, I would.”

I was told that for first the first time ever, foreign pilots had access to Russian military aircraft, provided they had enough money. You see, everything in the just collapsed Soviet Union was for sale. All they needed was someone to masquerade as a wealthy hedge fund manager looking for adventure.

No problem there.

And can you fly a MiG29?

No problem there either.

A month later, I was wearing the uniform of a major in the Russian Air Force, my hair cut military short, sitting in the backseat of a black Volga limo, sweating bullets.

“Don’t speak,” said my driver.

The guard shifted his Kalashnikov and ordered us to stop, looked at my fake ID card and waved us on. We were in Russia’s Zhukovky Airbase 100 miles north of Moscow, home of the country’s best interceptor fighter, the storied Fulcrum, or MiG-29.

I ended up spending a week at the top-secret base. That included daily turns in the centrifuge to make sure I was up to the G-forces demand by supersonic flight. Afternoons saw me in ejection training. There in my trainer, I had to shout “eject, eject, eject,” pull the right-hand lever under my seat, and then get blasted ten feet in the air, only to settle back down to earth.

As a known big spender, I was a pretty popular guy on the base, and I was invited to a party every night. Let me tell you that vodka is a really big deal in Russia, and I was not allowed to leave until I had finished my own bottle, straight.

In 1993, Russia was realigning itself with the west, and everyone was putting their best face going forward. I had been warned about this ahead of time and judiciously downed a shot glass of cooking oil every evening to ward off the worst effects of alcohol poisoning. It worked.

Preflight involved getting laced into my green super tight gravity suit, a three-hour project. Two women tied the necessary 300 knots, joking and laughing all the while. They wished me a good flight.

Next, I met my co-pilot, Captain A. Pavlov, Russia’s top test pilot. He quizzed me about my flight experience. I listed off the names: Laos, Cambodia, Thailand, Israel, Croatia, Serbia, Bosnia, Kuwait, Iraq, and Saudi Arabia. It was clear he still needed convincing.

Then I was strapped into the cockpit.

Oops!

All the instruments were in the Cyrillic alphabet….and were metric! They hadn’t told me about this, but I would deal with it.

We took off and went straight up, gaining 50,000 feet in two minutes. Yes, fellow pilots, that is a climb rate of an astounding 25,000 feet a minute. They call them interceptors for a reason. It was a humid day, and when we hit 50,000 feet, the air suddenly turned to snowflakes swirling around the cockpit.

Then we went through a series of violent spins, loops, and other evasive maneuvers (see my logbook entry below). Some of them seemed aeronautically impossible. I watched the Mach Meter carefully, it frequently danced up to the “10” level. Anything over ten is invariably fatal, as it ruptures your internal organs.

Then Pavlov said, “I guess you are a real pilot, and he handed the stick over to me. I put the fighter into a steep dive, gaining the maximum handbook speed of March 2.5, or 2.5 times the speed of sound, or 767.2 miles per hour in seconds. Let me tell you, there is nothing like diving a fighter from 90,000 feet to the earth at 767.2 miles per hour.

Then we found a wide river and buzzed that at 500 feet just under the speed of sound. Fly over any structure over the speed of sound and the resulting shock wave shatters concrete.

I noticed the fuel gages were running near empty and realized that the Russians had only given me enough fuel to fly for an hour. That’s so I wouldn’t hijack the plane and fly it to Finland. Still, Pavlov trusted me enough to let me land the plane, no small thing in a $30 million aircraft. I made a perfect three-point landing and taxied back to base.

I couldn’t help but notice that there was a MiG-25 Foxbat parked in the adjoining hanger and asked if it was available. They said “yes”, but only if I had $10,000 in cash on hand, thinking this was an impossibility. I said, “no problem” and whipped out my American Express gold card.

Their eyes practically popped out of their heads, as this amounted to a lifetime of earnings for the average Russian. They took a picture of the card, called in the number, and in five minutes I was good to go.

They asked when I wanted to fly, and as I was still in my gravity suite I said, “How about right now?” The fuel truck duly back up and in 20 minutes I was ready for takeoff, Pavlov once again my co-pilot. This time, he let me do the takeoff AND the landing.

The first thing I noticed was the missile trigger at the end of the stick. Then I asked the question that had been puzzling aeronautics analysts for years. “If the ceiling of the MiG-25 was 90,000 feet and the U-2 was at 100,000 feet, how did the Russians make up the last 10,000 feet?

 “It’s simple,” said Pavlov. Put on full power, stall out at 90,000 feet, then fire your rockets at the apex of the parabola to make up the distance. There was only one problem with this. If your stall forced you to eject, the survival rate was only 50%. That's because when the plane in free fall hit the atmosphere at 50,000 feet, it was like hitting a wall of concrete. I told him to go ahead, and he repeated the maneuver for my benefit.

It was worth the risk to get up to 90,000 feet. There you can clearly see the curvature of the earth, the sky above is black, you can see stars in the middle of the day, and your forward vision is about 400 miles. We were the highest men in the world at that moment. Again, I made a perfect three-point landing, thanks to flying all those Mustangs and Spitfires over the decades.

After my big flights, I was taken to a museum on the base and shown the wreckage of the U-2 spy plane flown by Francis Gary Powers shot down over Russia in 1960. After suffering a direct hit from a missile, there wasn’t much left of the U-2. However, I did notice a nameplate that said, “Lockheed Aircraft Company, Los Angeles, California.”

I asked, “Is it alright if I take this home? My mother worked at this factory during WWII building bombers.” My hosts looked horrified. “No, no, no, no. This is one of Russia’s greatest national treasures,” and they hustled me out of the building as fast as they could.

It's a good thing that I struck while the iron was hot as foreigners are no longer allowed to fly any Russian jets. And suddenly I have become very popular in Washington DC once again.

Stay Healthy,
John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

My MiG 25 in Russia

Russian Test Pilot A. Pavlov

 

Entries in my Logbook (Notice visit to leper colony on line 9)

 

U-2 Spyplane

 

 

 

 

 

 

 

  

https://www.madhedgefundtrader.com/wp-content/uploads/2022/04/mig25-e1650294282319.png 319 500 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-18 09:02:062022-04-18 16:03:07The Market Outlook for the Week Ahead, or Get Ready to Sell in May
Mad Hedge Fund Trader

April 14, 2022

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
April 14, 2022
Fiat Lux

Featured Trade:

(A BIOPHARMA STOCK BENT ON REDEMPTION)
(MRK), (BMY), (ABBV), (ORGN), (PFE), (VTRS), (MRNA), (BNTX), (CRSP), (VRTX), (BLUE), (BIIB)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-14 17:02:442022-04-14 16:42:49April 14, 2022
Mad Hedge Fund Trader

A Biopharma Stock Bent on Redemption

Biotech Letter

It looks like we’re about to bear witness to a redemption journey.

Once upon a time, Merck (MRK) was a major player in the cardiovascular sector. Over the years, it has gradually diminished to a minor league name.

However, Merck has plans to reverse this fortune and reclaim its dominance in the cardio market. To date, it has eight new drug approvals and a slew of expanded labels queued in the next couple of years.

This decision is evident in Merck’s move to outbid Bristol Myers Squibb (BMY) in the auction for Acceleron Pharma, shelling out a whopping $11.5 billion to boost its cardio pipeline considerably.

While the deal may seem like a massive risk, Merck is confident that this deal holds the potential to open up the path to single-product peak sales reaching $10 billion by the mid-2030s.

In fact, there’s no need to wait for long to see some solid proof of Merck’s multibillion-dollar bet, as Acceleron already has a candidate set to be put on display by the end of 2022 or early 2023. 

This Acceleron acquisition forms part of the “New Merck” touted when the company welcomed a new CEO and came on the heels of the success of the leadership that brought the mega-blockbuster cancer drug Keytruda.

It also signifies Merck’s conscious efforts to ease their heavily criticized over-dependence on Keytruda.

While the drug will lose patent protection after 2028, Keytruda still holds a significant portion of Merck’s sales. The treatment accounted for roughly 35% of the company’s total revenues last year.

The patent loss of a significant moneymaker is a typical problem for virtually every Big Pharma company, with AbbVie (ABBV) and Bristol Myers Squibb coming to mind as the most recent examples.

The go-to solution to this is pursuing mega-money mergers: AbbVie acquired Allergan for $63 billion while Bristol splurged on Celgene at $74 billion.

This quickly bolsters the existing pipelines and portfolios of the companies and assuages the fear of investors over impending revenue losses.

Instead of following this pattern, Merck did the opposite in 2021.

The company decided to downsize and established a spinoff segment: Organon (ORGN). The idea is to offload its biosimilars and other legacy products to focus on its core strengths.

This is reminiscent of Pfizer’s (PFE) move to spin out its Upjohn unit and merge it with Mylan to form Viatris (VTRS).

This move looks to have worked well for Merck and Organon as it allowed the parent company to focus on its blockbuster brands.

For instance, Bridion recorded a 28% year-over-year rise in 2021 to reach $1.53 billion in sales, while ProQuad reported a 14% increase to hit $2.14 billion.

Meanwhile, Gardasil rose to an impressive 44% to contribute $5.7 billion.

Even Merck’s Animal Health sector grew by 18% to record $5.6 billion.

There’s also Keytruda, which is projected to become the highest-selling drug at $24.3 billion by 2026.

These are only some of the blockbuster products in Merck’s portfolio expected to continue increasing revenues this 2022.

In addition, the company expects at least $5 billion from its COVID-19 antiviral drug Molnupiravir.

Looking at the trajectory and growth of the pipeline and existing programs, Merck estimates an additional 17% increase in its year-on-year revenue in 2022 to reach $56.1 billion to $57.6 billion.

Despite the move to establish a spinoff unit, the Acceleron deal hints at the possibility that Merck might be shifting to an open checkbook strategy.

Considering how relentlessly it pursued the deal, there’s a chance that the company would be at the bargaining table for a while in search of ways to protect itself against the pending Keytruda patent loss.

Some contenders for a potentially splashy offer from Merck are Moderna (MRNA) and BioNTech (BNTX), which could bolster the bigger company’s mRNA pipeline.

It can also splurge on gene therapy experts by targeting CRISPR Therapeutics (CRSP) and even Vertex (VRTX).

However, given bluebird bio’s (BLUE) flailing performance as of late, this small biotech could very well be a contender for a bargain deal. 

Speaking of discounted stocks, Biogen (BIIB) is also reportedly under consideration simply because of its deeply discounted price following its disastrous Alzheimer’s disease program.

Whatever move it makes, one thing is sure: Merck, with its $208 billion market capitalization, is in a healthy and stable place financially.

More importantly, it has an excellent product portfolio and an exciting pipeline.

It has shown remarkable growth in the past years and impressive efforts to secure a great future, making it a solid stock to buy and hold for a long time. 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-04-14 17:00:162022-04-14 16:48:33A Biopharma Stock Bent on Redemption
Page 7 of 13«‹56789›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top